Safety and efficacy of testosterone gel in the treatment of male hypogonadism
Kishore M Lakshman, Shehzad BasariaSection of Endocrinology, Diabetes, and Nutrition. Boston University School of Medicine, Boston Medical Center, Boston, MA, USAAbstract: Transdermal testosterone gels were first introduced in the US in 2000. Since then, they have emerged as a favorable mode of test...
Guardado en:
Autores principales: | Kishore M Lakshman, Shehzad Basaria |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2009
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a3f38ab65bf44289b982b69c16cd4fea |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Testosterone replacement therapy among elderly males: the Testim Registry in the US (TRiUS)
por: Bhattacharya RK, et al.
Publicado: (2012) -
Cognitive effects of testosterone and finasteride administration in older hypogonadal men
por: Borst SE, et al.
Publicado: (2014) -
Testosterone depot injection in male hypogonadism: a critical appraisal
por: Aksam A Yassin, et al.
Publicado: (2008) -
Guidelines for the diagnosis and treatment of testosterone deficiency (hypogonadism) in male patients with diabetes mellitus (Draft)
por: Galina Afanas'evna Melnichenko, et al.
Publicado: (2017) -
d-Chiro-Inositol improves testosterone levels in older hypogonadal men with low-normal testosterone: a pilot study
por: Maurizio Nordio, et al.
Publicado: (2021)